Alchemab’s new CEO is the company’s co-founder and hitherto CSO, Jane Osbourn.
FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug ...
The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Admi ...
AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider.
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...
Who is MEDIMMUNE INC /DE? MEDIMMUNE INC /DE has an estimated net worth of $8.2 Million. This is based on reported shares in Vanda Pharmaceuticals Inc.. Attention insiders: Dive deeper into market ...
MedImmune will explore the target, linker, warhead selection: Do's and Don’ts; five rights of creation of the best optimized fit-for-purpose ADCs; internalisation of ADCs – how to improve ...
Since Sunday, Tropical Storm Enteng (international name: Yagi) has brought rains and caused heavy flooding in Metro Manila and its neighboring cities, with Signal No. 2 raised in nine areas in Luzon.